C149851_DHSC: OHID: Anorectal malformations Evidence Map
Department of Health and Social Care (London)contractContracts Finder ↗Ref CF-1441400D0O000000rwimUAASME suitablecomplete
Estimated value
£19k
Awarded value
£17k
Awarded 20 Mar 2023
Suppliers
1
Lots
1
1 awarded
Published
24 Mar 2023
Deadline 08 Mar 2023
Other contracts from Department of Health and Social Care (London)· 10
Most recent notices published by the same contracting authority.
| Title | Type | Value | Published |
|---|---|---|---|
| De-risking the Uk's antibiotic supply chain 2026 | contract | £80k | 21 Jan 2026 |
| Children and Young People Mental Health Early Intervention Hubs | call off | £5.5m | 10 Jan 2025 |
| HPV Self-sampling cost effectiveness model | call off | £300k | 14 Oct 2024 |
| DHSC: SC&I: Lampard Inquiry Transcription, Translation and Interpretation | contract | £39k | 01 Oct 2024 |
| Opportunity awarded | contract | £100k | 09 Aug 2024 |
| DHSC_PCP_HPV Self-sampling Cost Effectiveness Model | contract | — | 15 Jul 2024 |
| Screening Programme FY2024/25 | call off | — | 12 Jun 2024 |
| Cost-effectiveness model of prostate cancer screening 24/25 | contract | £100k | 07 Mar 2024 |
| DHSC: ASC: Leadership Development Programme for ASCW | contract | — | 30 Oct 2023 |
| OHID: MHISS - Modernising Health Intelligence Systems | call off | £661k | 02 Oct 2023 |
Other contracts awarded to COSTELLO MEDICAL CONSULTING LIMITED· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Health Economics Feasibility Study- Specialised Commissioning | contract | £24k | 17 Oct 2023 |
| DHSC: OHID: Metachromatic Leukodystrophy (MLD) Evidence Map | contract | £16k | 20 Mar 2023 |
| Consultancy Services for Population Health Programme | contract | £44k | 29 Nov 2022 |
| Evidence Map on Screening for Cytomegalovirus | contract | £50k | 18 Jun 2021 |
| PHE - Corporate - Evidence Map on Biotinidase Deficiency | contract | £6k | 09 Jun 2021 |
| PHE - Corporate - Asymptomatic Bacteriuria Screening in Pregnancy | contract | £81k | 26 May 2021 |
| PHE - Corporate - Evidence Map on Neuronal Ceroid Lipofuscinosis Type 2 | contract | £11k | 21 Apr 2021 |
| PHE - Corporate - Screening for Duchenne Muscular Dystrophy | contract | £15k | 31 Mar 2021 |
| PHE - Corporate - A Clinical and Cost Effectiveness Model on Formalising New-born Screening for β-thalassaemia Major | contract | £81k | 03 Nov 2020 |
| PHE - Corporate - Ultrasound Screening for Fetal Presentation at 36 Weeks | contract | £11k | 02 Sept 2020 |